Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): Roche - appeal received
|
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): Roche - appeal received
16 May 2011 (239.76 Kb 9 sec) |
This page was last updated: 13 May 2011